Nothing Special   »   [go: up one dir, main page]

CERN Accelerating science

CERN Document Server 3 Datensätze gefunden  Die Suche hat 1.02 Sekunden gedauert. 
1.
“Particle therapy - future for the Baltic states?” – synthesis of the expert workshop report / Paļskis, Kristaps (Riga Tech. U. ; CERN) ; Korobeinikova, Erika ; Bogorada-Saukuma, Dace ; Camarda, Anna Maria (CNAO, Milan) ; Taylor, Rebecca (CERN ; Imperial Coll., London) ; Benedetto, Elena ; Mamis, Edgars (CERN ; Latvia U.) ; Radziņa, Maija ; Ērglis, Andrejs (Latvia U.) ; Adliene, Diana et al.
Background Baltic States remains one of the few regions in the Europe without a dedicated particle therapy center. An initiative since 2021 has been started by CERN Baltic Group on a novel particle therapy center development in the region in partnership with CERN NIMMS collaboration. [...]
2024 - 8 p. - Published in : Health Technol. 14 (2024) 965-972 Fulltext: PDF;
2.
Target Development towards First Production of High-Molar- Activity $^{44g}$Sc and $^{47}$Sc by Mass Separation at CERN-MEDICIS / Mamis, Edgars (CERN ; Latvia U.) ; Duchemin, Charlotte (CERN) ; Berlin, Valentina (CERN) ; Bernerd, Cyril (CERN) ; Bovigny, Mathieu (CERN) ; Chevallay, Eric (CERN) ; Crepieux, Bernard (CERN) ; Gadelshin, Vadim Maratovich (Mainz U., Inst. Phys.) ; Heinke, Reinhard (CERN) ; Hernandez, Ronaldo Mendez (CERN ; Havana, ISCTN) et al.
The radionuclides 43Sc,  44g/mSc, and 47Sc can be produced cost-effectively in sufficient yield for medical research and applications by irradiating  natTi and  natV target materials with protons. Maximizing the production yield of the therapeutic 47Sc in the highest cross section energy range of 24–70 MeV results in the co-production of long-lived, high-γ-ray-energy 46Sc and 48Sc contaminants if one does not use enriched target materials. [...]
2024 - 28 p. - Published in : Pharmaceuticals 17 (2024) 390 Fulltext: PDF;
3.
Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go? / Radzina, Maija (Latvia U. ; CERN) ; Saule, Laura (Latvia U.) ; Mamis, Edgars (Latvia U. ; CERN) ; Koester, Ulli (Laue-Langevin Inst.) ; Cocolios, Thomas Elias (Leuven U.) ; Pajuste, Elina (Latvia U.) ; Kalnina, Marika (Unlisted) ; Palskis, Kristaps (CERN ; Riga Tech. U.) ; Sawitzki, Zoe (Leuven U.) ; Talip, Zeynep (PSI, Villigen) et al.
Background In order to support the ongoing research across Europe to facilitate access to novel radionuclides, the PRISMAP consortium (European medical radionuclides programme) was established to offer the broadest catalog of non-conventional radionuclides for medical and translational research. The aim of this article is to introduce readers with current status of novel radionuclides in Europe. Main body A consortium questionnaire was disseminated through the PRISMAP consortium and user community, professional associations and preclinical/clinical end users in Europe and the current status of clinical end-users in nuclear medicine were identified. [...]
2023 - 16 p. - Published in : EJNMMI Radiopharm. Chem. 8 (2023) 27 Fulltext: PDF;

Sehen Sie auch: ähnliche Autornamen
3 Mamis, E
Sind Sie interessiert über neue Ergebnisse zu dieser Suchabfrage informiert zu werden?
Definieren Sie eine persönliche E-Mail-Benachrichtigung oder abonnieren Sie den RSS Feed.
Haben Sie nicht gefunden was Sie suchten? Versuchen Sie Ihre Suche auf anderen Servern:
Mamis, Edgars in Amazon
Mamis, Edgars in CERN EDMS
Mamis, Edgars in CERN Intranet
Mamis, Edgars in CiteSeer
Mamis, Edgars in Google Books
Mamis, Edgars in Google Scholar
Mamis, Edgars in Google Web
Mamis, Edgars in IEC
Mamis, Edgars in IHS
Mamis, Edgars in INSPIRE
Mamis, Edgars in ISO
Mamis, Edgars in KISS Books/Journals
Mamis, Edgars in KISS Preprints
Mamis, Edgars in NEBIS
Mamis, Edgars in SLAC Library Catalog
Mamis, Edgars in Scirus